Dawson-Hahn Elizabeth E, Mickan Sharon, Onakpoya Igho, Roberts Nia, Kronman Matthew, Butler Chris C, Thompson Matthew J
Department of Pediatrics, University of Washington, Seattle, WA, USA.
Center for Child Health, Behavior and Development, Seattle Children's Research Institute, Seattle, WA, USA.
Fam Pract. 2017 Sep 1;34(5):511-519. doi: 10.1093/fampra/cmx037.
To summarize the evidence comparing the effectiveness of short and long courses of oral antibiotics for infections treated in outpatient settings.
We identified systematic reviews of randomized controlled trials for children and adults with bacterial infections treated in outpatient settings from Medline, Embase, CINAHL, Cochrane Database of Systematic Reviews and The Database of Review of Effects. Data were extracted on the primary outcome of clinical resolution and secondary outcomes.
We identified 30 potential reviews, and included 9. There was no difference in the clinical cure for children treated with short or long course antibiotics for Group A streptococcal tonsillopharyngitis (OR 1.03, 95% CI:0.97, 1.11); community acquired pneumonia (RR 0.99, 95% CI:0.97, 1.01); acute otitis media [<2 years old OR: 1.09 (95% CI:0.76, 1.57); ≥2 years old OR: 0.85 (95% CI:0.60, 1.21)]; or urinary tract infection (RR 1.06, 95% CI:0.64, 1.76). There was no difference in the clinical cure for adults treated with short or long course antibiotics for acute bacterial sinusitis (RR 0.95, 95% CI:0.81, 1.21); uncomplicated cystitis in non-pregnant women (RR 1.10, 95% CI:0.96, 1.25), or elderly women (RR: 0.98, 95% CI:0.62, 1.54); acute pyelonephritis (RR 1.03, 95% CI:0.80, 1.32); or community acquired pneumonia (RR: 0.96, 95% CI:0.74, 1.26). We found inadequate evidence about the effect on antibiotic resistance.
This overview of systematic reviews has identified good quality evidence that short course antibiotics are as effective as longer courses for most common infections managed in ambulatory care. The impact on antibiotic resistance and associated treatment failure requires further study.
总结比较短期和长期口服抗生素治疗门诊感染有效性的证据。
我们从Medline、Embase、CINAHL、Cochrane系统评价数据库和效果评价数据库中检索了关于门诊治疗的儿童和成人细菌感染的随机对照试验的系统评价。提取了临床缓解的主要结局和次要结局的数据。
我们识别出30项潜在的评价,纳入了9项。对于A组链球菌性扁桃体咽炎(比值比1.03,95%可信区间:0.97,1.11)、社区获得性肺炎(风险比0.99,95%可信区间:0.97,1.01)、急性中耳炎[<2岁儿童比值比:1.09(95%可信区间:0.76,1.57);≥2岁儿童比值比:0.85(95%可信区间:0.60,1.21)]或尿路感染(风险比1.06,95%可信区间:0.64,1.76),短期或长期抗生素治疗儿童的临床治愈率无差异。对于急性细菌性鼻窦炎(风险比0.95,95%可信区间:0.81,1.21)、非孕妇单纯性膀胱炎(风险比1.10,95%可信区间:0.96,1.25)或老年女性(风险比:0.98,95%可信区间:0.62,1.54)、急性肾盂肾炎(风险比1.03,95%可信区间:0.80,1.32)或社区获得性肺炎(风险比:0.96,95%可信区间:0.74,1.26),短期或长期抗生素治疗成人的临床治愈率无差异。我们发现关于对抗生素耐药性影响的证据不足。
该系统评价概述发现了高质量证据,即短期抗生素治疗在门诊护理中对大多数常见感染的效果与长期治疗一样好。对抗生素耐药性及相关治疗失败的影响需要进一步研究。